Your browser doesn't support javascript.
loading
Modelling the impact of respiratory syncytial virus (RSV) vaccine and immunoprophylaxis strategies in New Zealand.
Prasad, Namrata; Read, Jonathan M; Jewell, Christopher; Waite, Ben; Trenholme, Adrian A; Huang, Q Sue; Grant, Cameron C; Newbern, E Claire; Hogan, Alexandra B.
Afiliação
  • Prasad N; National Centre for Biosecurity and Infectious Disease, Institute of Environmental Science and Research, Upper Hutt, Wellington, New Zealand; Department of Paediatrics: Child & Youth Health, University of Auckland, Auckland, New Zealand. Electronic address: namrata.prasad@esr.cri.nz.
  • Read JM; Centre for Health Informatics, Computing, and Statistics, Lancaster Medical School, Lancaster University, Lancaster, United Kingdom.
  • Jewell C; Centre for Health Informatics, Computing, and Statistics, Lancaster Medical School, Lancaster University, Lancaster, United Kingdom.
  • Waite B; National Centre for Biosecurity and Infectious Disease, Institute of Environmental Science and Research, Upper Hutt, Wellington, New Zealand.
  • Trenholme AA; Kidz First Children's Hospital, Counties Manukau District Health Board, Auckland, New Zealand.
  • Huang QS; National Centre for Biosecurity and Infectious Disease, Institute of Environmental Science and Research, Upper Hutt, Wellington, New Zealand.
  • Grant CC; Department of Paediatrics: Child & Youth Health, University of Auckland, Auckland, New Zealand; General Paediatrics, Starship Children's Hospital, Auckland, New Zealand.
  • Newbern EC; National Centre for Biosecurity and Infectious Disease, Institute of Environmental Science and Research, Upper Hutt, Wellington, New Zealand.
  • Hogan AB; MRC Centre for Global Infectious Disease Analysis, School of Public Health, Imperial College London, London, United Kingdom.
Vaccine ; 39(31): 4383-4390, 2021 07 13.
Article em En | MEDLINE | ID: mdl-34147296

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Vírus Sincicial Respiratório Humano / Infecções por Vírus Respiratório Sincicial / Vacinas contra Vírus Sincicial Respiratório Limite: Child / Humans / Infant País/Região como assunto: Oceania Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Vírus Sincicial Respiratório Humano / Infecções por Vírus Respiratório Sincicial / Vacinas contra Vírus Sincicial Respiratório Limite: Child / Humans / Infant País/Região como assunto: Oceania Idioma: En Ano de publicação: 2021 Tipo de documento: Article